Roflumilast

Details

Files

Generic Name:

Roflumilast

Project Status:

Complete

Therapeutic Area:

Chronic obstructive pulmonary disease

Manufacturer:

Nycomed Canada Inc.

Call for patient/clinician input open:

November 18, 2010

Brand Name:

Daxas

Project Line:

Reimbursement Review

Project Number:

SR0218-000

Call for patient/clinician input closed:

January 24, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Chronic obstructive pulmonary disease (COPD)

Recommendation Type:

Do not list

Final Recommendation:

July 27, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : November 30, 2010